NYSE:MET - Metlife Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
Get Started
$45.79 +0.06 (+0.13 %)
(As of 06/20/2018 04:00 PM ET)
Previous Close$45.79
Today's Range$45.53 - $45.99
52-Week Range$43.38 - $55.91
Volume7.35 million shs
Average Volume6.45 million shs
Market Capitalization$47.40 billion
P/E Ratio10.18
Dividend Yield3.60%
Beta1.19
Metlife logoMetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, tort settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, the company offers automobile, homeowners', and personal excess liability, as well as small business owners' property, liability, and business interruption insurance products. Further, it provides fixed annuities and pension products; medical and credit insurance products; variable, universal, term, endowment, and whole life insurance products; variable, and fixed and indexed-linked annuities; and protection against costs of long-term health care services. MetLife, Inc. has a strategic alliance with Ernst & Young LLP. The company serves individuals, corporations and their employees, and other institutions through independent agents, property and casualty specialists, sales forces, sales teams and relationship managers, and other organizations, as well as through career agency, bancassurance, direct marketing, brokerage, and other third-party distribution and e-commerce channels. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.

Receive MET News and Ratings via Email

Sign-up to receive the latest news and ratings for MET and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Life insurance
Sub-IndustryLife & Health Insurance
SectorFinance
SymbolNYSE:MET
CUSIP59156R10
Webwww.metlife.com
Phone212-578-9500

Debt

Debt-to-Equity Ratio0.30
Current Ratio0.15
Quick Ratio0.15

Price-To-Earnings

Trailing P/E Ratio10.18
Forward P/E Ratio9.03
P/E Growth0.8

Sales & Book Value

Annual Sales$62.09 billion
Price / Sales0.75
Cash Flow$4.3944 per share
Price / Cash10.42
Book Value$55.94 per share
Price / Book0.82

Profitability

EPS (Most Recent Fiscal Year)$4.50
Net Income$4.01 billion
Net Margins6.48%
Return on Equity8.70%
Return on Assets0.68%

Miscellaneous

Employees49,000
Outstanding Shares1,016,530,000

Metlife (NYSE:MET) Frequently Asked Questions

What is Metlife's stock symbol?

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

How often does Metlife pay dividends? What is the dividend yield for Metlife?

Metlife announced a quarterly dividend on Tuesday, April 24th. Investors of record on Monday, May 7th will be paid a dividend of $0.42 per share on Wednesday, June 13th. This represents a $1.68 dividend on an annualized basis and a yield of 3.67%. The ex-dividend date of this dividend is Friday, May 4th. This is an increase from Metlife's previous quarterly dividend of $0.40. View Metlife's Dividend History.

How will Metlife's stock buyback program work?

Metlife declared that its Board of Directors has initiated a share repurchase plan on Tuesday, May 22nd 2018, which authorizes the company to repurchase $1,500,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 3.1% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company's management believes its stock is undervalued.

How were Metlife's earnings last quarter?

Metlife Inc (NYSE:MET) released its quarterly earnings results on Wednesday, May, 2nd. The financial services provider reported $1.36 EPS for the quarter, topping the consensus estimate of $1.17 by $0.19. The financial services provider had revenue of $15.15 billion for the quarter, compared to the consensus estimate of $15.52 billion. Metlife had a return on equity of 8.70% and a net margin of 6.48%. The company's quarterly revenue was up .6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.20 earnings per share. View Metlife's Earnings History.

What price target have analysts set for MET?

18 analysts have issued 1-year price targets for Metlife's stock. Their predictions range from $47.00 to $78.00. On average, they expect Metlife's share price to reach $57.1333 in the next year. View Analyst Ratings for Metlife.

What are Wall Street analysts saying about Metlife stock?

Here are some recent quotes from research analysts about Metlife stock:
  • 1. According to Zacks Investment Research, "MetLife’s shares have outperformed its industry in a year's time. Its efforts to streamline business, only to focus on core business, are really impressive. Its revenues grew in 2017 after declining for two years and the trend is likely to continue in 2018. Its strong international operations and disciplined capital management should drive long-term growth. The stock has seen the Zacks Consensus Estimate for current-year earnings being revised 2.9% upward over the last 30 days. MetLife, Inc.’s first-quarter earnings of $1.36 per share beat the Zacks Consensus Estimate by 16.2% but declined 7% year over year. The quarter benefited from favorable underwriting, volume growth and a favorable impact of the tax reform. Nevertheless, exposure to catastrophe losses and investment in efficiency programs will put pressure on margins." (5/10/2018)
  • 2. Wells Fargo & Co analysts commented, "We hosted investor meetings with MetLife today (March 15) at the company’s NYC headquarters. From MET were Steven Kandarian, President, Chairman & CEO; John Hele, EVP & CFO; and John Hall, SVP & Head of IR. Investors were focused on MET’s material weaknesses (MW), unit cost initiative (UCI), long term care reserves, Brighthouse exchange offer, and reinsurance opportunities with MetLife Holdings. To us, the investment case for MET remains unchanged – faster growth in less capital intensive and less volatile businesses should lower the company’s cost of equity, which in turn should allow MetLife to achieve a higher ROE spread as well as a higher valuation multiple. We reiterate our Outperform rating on MET, which is also our top pick." (3/16/2018)

Are investors shorting Metlife?

Metlife saw a increase in short interest in May. As of May 31st, there was short interest totalling 14,613,412 shares, an increase of 29.6% from the May 15th total of 11,275,289 shares. Based on an average daily trading volume, of 4,610,897 shares, the days-to-cover ratio is presently 3.2 days. Currently, 1.7% of the company's shares are sold short. View Metlife's Current Options Chain.

Who are some of Metlife's key competitors?

Who are Metlife's key executives?

Metlife's management team includes the folowing people:
  • Mr. Steven Albert Kandarian, Chairman, Pres & CEO (Age 65)
  • Mr. John Carroll Ramsey Hele, Exec. VP & CFO (Age 60)
  • Mr. Steven Jeffery Goulart, Chief Investment Officer & Exec. VP (Age 59)
  • Mr. Martin J. Lippert, Head of Global Technology & Operations and Exec. VP (Age 58)
  • Ms. Kirstie Traas, Head of Operations

Has Metlife been receiving favorable news coverage?

News stories about MET stock have been trending somewhat positive on Wednesday, Accern Sentiment Analysis reports. The research group identifies negative and positive press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Metlife earned a news impact score of 0.19 on Accern's scale. They also assigned media stories about the financial services provider an impact score of 46.59 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near future.

Who are Metlife's major shareholders?

Metlife's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BOARD OF DIRECTORS OF METLIFE INC (15.00%), BlackRock Inc. (7.32%), Franklin Resources Inc. (2.47%), Massachusetts Financial Services Co. MA (2.43%), Epoch Investment Partners Inc. (1.15%) and Northern Trust Corp (1.08%). Company insiders that own Metlife stock include Christopher G Townsend, Frans Hijkoop, Gerald L Hassell, James M Kilts, Maria R Morris and Peter M Carlson. View Institutional Ownership Trends for Metlife.

Which major investors are selling Metlife stock?

MET stock was sold by a variety of institutional investors in the last quarter, including OppenheimerFunds Inc., Lord Abbett & CO. LLC, Natixis, Franklin Resources Inc., Swiss National Bank, Northern Trust Corp, Thrivent Financial for Lutherans and Loomis Sayles & Co. L P. View Insider Buying and Selling for Metlife.

Which major investors are buying Metlife stock?

MET stock was purchased by a variety of institutional investors in the last quarter, including Diamond Hill Capital Management Inc., Old Mutual Global Investors UK Ltd., Ceredex Value Advisors LLC, BlackRock Inc., Prudential Financial Inc., Epoch Investment Partners Inc., O Shaughnessy Asset Management LLC and Boston Partners. Company insiders that have bought Metlife stock in the last two years include Gerald L Hassell and James M Kilts. View Insider Buying and Selling for Metlife.

How do I buy shares of Metlife?

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Metlife's stock price today?

One share of MET stock can currently be purchased for approximately $45.79.

How big of a company is Metlife?

Metlife has a market capitalization of $47.40 billion and generates $62.09 billion in revenue each year. The financial services provider earns $4.01 billion in net income (profit) each year or $4.50 on an earnings per share basis. Metlife employs 49,000 workers across the globe.

How can I contact Metlife?

Metlife's mailing address is 200 Park Avenue, New York NY, 10166. The financial services provider can be reached via phone at 212-578-9500.


MarketBeat Community Rating for Metlife (MET)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  684 (Vote Outperform)
Underperform Votes:  397 (Vote Underperform)
Total Votes:  1,081
MarketBeat's community ratings are surveys of what our community members think about Metlife and other stocks. Vote "Outperform" if you believe MET will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MET will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/20/2018 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.